bpc 157 type 1 diabetes BPC-157 BPC-157 gene-containing constructs enabling: (1)
Description
Published preclinical data in rodents suggests doses equivalent to 200mg+ in humans produce off-target effects on folate metabolism and S-adenosylmethionine (SAMe) pools
Some patients have anecdotally reported feeling anxious, shaky, or jittery whilst taking the medication
Research suggests that it works by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat accumulation), particularly in stubborn fat deposits such as the abdomen and thighs
European Journal of Pharmacology, 570(1-3), 212221
Are there any risks or side effects with PRP
